Open Access. Powered by Scholars. Published by Universities.®
![Digital Commons Network](http://assets.bepress.com/20200205/img/dcn/DCsunburst.png)
Translational Medical Research Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Statin (2)
- Stroke (2)
- Acute limb ischemia (1)
- Acute type B aortic dissection (1)
- Alirocumab (1)
-
- Alteplase (1)
- Antibiotics (1)
- Aspirin (1)
- Atrial fibrillation (1)
- Cardiovascular risk (1)
- Chronic stable angina (1)
- Elderly (1)
- Endovascular (1)
- Ezetimibe (1)
- Female veteran (1)
- Fenestration (1)
- Heart failure with reduced ejection fraction (1)
- Infective endocarditis (1)
- Lower limb malperfusion (1)
- Medication adherence (1)
- Myalgias (1)
- Out-of-pocket costs (1)
- PCSK9 inhibitors (1)
- Patient trust (1)
- Ranolazine (1)
- Red yeast rice (1)
- Statin alternatives (1)
- Statin-intolerance (1)
- Stenting (1)
- T-PA (1)
Articles 1 - 8 of 8
Full-Text Articles in Translational Medical Research
Social Determinants May Limit The Success Of Pcsk9 Inhibitors, An Effective Treatment For Hyperlipidemia In Statin-Intolerant Patients, Abigail C. Kuplicki
Social Determinants May Limit The Success Of Pcsk9 Inhibitors, An Effective Treatment For Hyperlipidemia In Statin-Intolerant Patients, Abigail C. Kuplicki
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Moriarty PM, Thompson PD, Cannon CP, et al. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. J. Clin. Lipidol. 2015;9(6):758-769. https://doi.org/10.1016/j.jacl.2015.08.006
for a statin-intolerant patient with hyperlipidemia.
Evaluating The Use Of Cheaper, Less Effective Medications In Patients With Cost-Based Medication Nonadherence, Muneer F. Hasso
Evaluating The Use Of Cheaper, Less Effective Medications In Patients With Cost-Based Medication Nonadherence, Muneer F. Hasso
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Sangaralingham LR, Sangaralingham SJ, Shah ND, Yao X, Dunlay SM. Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure. Circ Heart Fail. 2018;11(2):e004302. https://doi.org/10.1161/circheartfailure.117.004302
for a patient with low medication adherence rates due to the high out-of-pocket costs of newer medications.
Partial Outpatient Oral Antibiotic Treatment Of Infective Endocarditis Is Non-Inferior To Inpatient Intravenous Antibiotic Therapy, Nicholas J. Murphy
Partial Outpatient Oral Antibiotic Treatment Of Infective Endocarditis Is Non-Inferior To Inpatient Intravenous Antibiotic Therapy, Nicholas J. Murphy
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Iversen K, Ihlemann N, Gill SU, et al. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis. N Engl J Med. 2019; 380:415-424. https://doi.org/10.1056/NEJMoa1808312
for a patient with infective endocarditis and intravenous drug use with desire to leave the hospital.
Endovascular Branch Fenestration And/Or Stenting May Be A Viable Treatment Option For Lower Limb Malperfusion Due To Acute Type B Aortic Dissection, Matthew Henry
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report appraising Norton EL, Williams DM, Kim KM, et al. Management of acute type B aortic dissection with malperfusion via endovascular fenestration/stenting [published online September 30, 2019]. J Thorac Cardiovasc Surg. 2019. https://doi.org/10.1016/j.jtcvs.2019.09.065
Ranolazine Decreases Weekly Anginal Episodes In Patients With Chronic Stable Angina And Type 2 Diabetes, Hisham Kaddurah
Ranolazine Decreases Weekly Anginal Episodes In Patients With Chronic Stable Angina And Type 2 Diabetes, Hisham Kaddurah
Clinical Research in Practice: The Journal of Team Hippocrates
The author reflects on the meaningful difference between statistical and clinical significance.
Reframing Outcome Measures For Thrombolytics In Acute Ischemic Stroke, Brandon Baker, Charles W. Kropf, Nicholus Yee, James Peter Meza
Reframing Outcome Measures For Thrombolytics In Acute Ischemic Stroke, Brandon Baker, Charles W. Kropf, Nicholus Yee, James Peter Meza
Clinical Research in Practice: The Journal of Team Hippocrates
An informed consent conversation examining relevant research and discussing the potential benefits and harms of thrombolytic therapy in acute stroke.
We Have No Real Evidence Related To Anticoagulation Plus Aspirin For Stroke Prevention In Atrial Fibrillation, Yuxiang Wang
We Have No Real Evidence Related To Anticoagulation Plus Aspirin For Stroke Prevention In Atrial Fibrillation, Yuxiang Wang
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Flaker GC, Gruber M, Connolly SJ, et al. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Am Heart J. 2006;152:967-973. doi: 10.1016/j.ahj.2006.06.024
Statin Therapy For Elderly Patients Should Be Assessed For Each Individual, Raymond Gong
Statin Therapy For Elderly Patients Should Be Assessed For Each Individual, Raymond Gong
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623-30. doi:10.1016/S0140-6736(02)11600-X